NO995030D0 - 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister - Google Patents

5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Info

Publication number
NO995030D0
NO995030D0 NO995030A NO995030A NO995030D0 NO 995030 D0 NO995030 D0 NO 995030D0 NO 995030 A NO995030 A NO 995030A NO 995030 A NO995030 A NO 995030A NO 995030 D0 NO995030 D0 NO 995030D0
Authority
NO
Norway
Prior art keywords
imidazolinylamino
alpha
compounds useful
adrenoceptor agonists
benzimidazole compounds
Prior art date
Application number
NO995030A
Other languages
English (en)
Other versions
NO995030L (no
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Glen Edward Mieling
Nick Nikolaides
Raymond Todd Henry
Russell James Sheldon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO995030D0 publication Critical patent/NO995030D0/no
Publication of NO995030L publication Critical patent/NO995030L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO995030A 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister NO995030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4231697P 1997-04-15 1997-04-15
PCT/IB1998/000540 WO1998046595A1 (en) 1997-04-15 1998-04-09 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists

Publications (2)

Publication Number Publication Date
NO995030D0 true NO995030D0 (no) 1999-10-15
NO995030L NO995030L (no) 1999-12-15

Family

ID=21921202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995030A NO995030L (no) 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Country Status (12)

Country Link
EP (1) EP0975627A1 (no)
JP (1) JP2001519828A (no)
KR (1) KR20010006440A (no)
CN (1) CN1256691A (no)
AU (1) AU6514498A (no)
BR (1) BR9808904A (no)
CA (1) CA2285610A1 (no)
HU (1) HUP0002242A2 (no)
ID (1) ID24081A (no)
IL (1) IL132384A0 (no)
NO (1) NO995030L (no)
WO (1) WO1998046595A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704972B2 (en) 1994-08-04 1999-05-13 H. Lundbeck A/S Novel benzimidazole derivatives
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
CA2311344C (en) * 1997-11-24 2006-02-07 The Procter & Gamble Company 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
US20040167194A1 (en) * 2003-02-20 2004-08-26 Randall Jared Lynn Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN110540523B (zh) * 2018-07-05 2021-02-19 安徽圣诺贝化学科技有限公司 一种制备磺基取代苯并咪唑及其衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
AU704972B2 (en) * 1994-08-04 1999-05-13 H. Lundbeck A/S Novel benzimidazole derivatives

Also Published As

Publication number Publication date
JP2001519828A (ja) 2001-10-23
WO1998046595A1 (en) 1998-10-22
HUP0002242A2 (hu) 2001-04-28
AU6514498A (en) 1998-11-11
ID24081A (id) 2000-07-06
CA2285610A1 (en) 1998-10-22
NO995030L (no) 1999-12-15
CN1256691A (zh) 2000-06-14
BR9808904A (pt) 2005-02-22
EP0975627A1 (en) 2000-02-02
IL132384A0 (en) 2001-03-19
KR20010006440A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
NO992470D0 (no) 2-amidazolinyl-amino-indolforbindelser anvendelige som &lt;alfa&gt;-2-adreno-reseptoragonister
DK1102762T3 (da) 2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister
NO20001141D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
NO20001142D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001139D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20014824L (no) Bicykliske heteroaromatiske forbindelser anvendelige som LH- agonister
FI962800A0 (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
FI970328A0 (fi) Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa
NO20030098D0 (no) &lt;Beta&gt;3 adrenergiske agonister
NO20032059D0 (no) Peroksisomprolferatoraktiverte reseptoralfa-agonister
FI954738A7 (fi) Tetrasykliini yhdisteet dopamiiniagonisteina
NO992498L (no) Guanidinylheterocykelforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO983594D0 (no) Heterosykliske tioetere som additiver for smöremidler
NO994106L (no) Oksazolidiner som 5-HT2A-antagonister
NO992500D0 (no) 2-imidazolinylaminobenzoksazolforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
NO995030D0 (no) 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som &lt;alfa&gt;-2-adrenoseptoragonister
ID30056A (id) Agonis-agonis 5-htif
NO992503D0 (no) Guanidinylamino heterocykelforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO992502D0 (no) 2-Imidazolinylaminoindazolforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO20032582D0 (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
DE59901862D1 (de) Substituierte (4-brompyrazol-3-yl)benzazole
ID18481A (id) 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2
NO20006214L (no) &lt;alfa&gt;-(1-piperaziny1)acetamidoarenkarboksylsyrederivater som antidiabetiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application